Cargando…

Exploring drug combinations in genetic interaction network

BACKGROUND: Drug combination that consists of distinctive agents is an attractive strategy to combat complex diseases and has been widely used clinically with improved therapeutic effects. However, the identification of efficacious drug combinations remains a non-trivial and challenging task due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yin-Ying, Xu, Ke-Jia, Song, Jiangning, Zhao, Xing-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348050/
https://www.ncbi.nlm.nih.gov/pubmed/22595004
http://dx.doi.org/10.1186/1471-2105-13-S7-S7
_version_ 1782232360596537344
author Wang, Yin-Ying
Xu, Ke-Jia
Song, Jiangning
Zhao, Xing-Ming
author_facet Wang, Yin-Ying
Xu, Ke-Jia
Song, Jiangning
Zhao, Xing-Ming
author_sort Wang, Yin-Ying
collection PubMed
description BACKGROUND: Drug combination that consists of distinctive agents is an attractive strategy to combat complex diseases and has been widely used clinically with improved therapeutic effects. However, the identification of efficacious drug combinations remains a non-trivial and challenging task due to the huge number of possible combinations among the candidate drugs. As an important factor, the molecular context in which drugs exert their functions can provide crucial insights into the mechanism underlying drug combinations. RESULTS: In this work, we present a network biology approach to investigate drug combinations and their target proteins in the context of genetic interaction networks and the related human pathways, in order to better understand the underlying rules of effective drug combinations. Our results indicate that combinatorial drugs tend to have a smaller effect radius in the genetic interaction networks, which is an important parameter to describe the therapeutic effect of a drug combination from the network perspective. We also find that drug combinations are more likely to modulate functionally related pathways. CONCLUSIONS: This study confirms that the molecular networks where drug combinations exert their functions can indeed provide important insights into the underlying rules of effective drug combinations. We hope that our findings can help shortcut the expedition of the future discovery of novel drug combinations.
format Online
Article
Text
id pubmed-3348050
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33480502012-05-09 Exploring drug combinations in genetic interaction network Wang, Yin-Ying Xu, Ke-Jia Song, Jiangning Zhao, Xing-Ming BMC Bioinformatics Proceedings BACKGROUND: Drug combination that consists of distinctive agents is an attractive strategy to combat complex diseases and has been widely used clinically with improved therapeutic effects. However, the identification of efficacious drug combinations remains a non-trivial and challenging task due to the huge number of possible combinations among the candidate drugs. As an important factor, the molecular context in which drugs exert their functions can provide crucial insights into the mechanism underlying drug combinations. RESULTS: In this work, we present a network biology approach to investigate drug combinations and their target proteins in the context of genetic interaction networks and the related human pathways, in order to better understand the underlying rules of effective drug combinations. Our results indicate that combinatorial drugs tend to have a smaller effect radius in the genetic interaction networks, which is an important parameter to describe the therapeutic effect of a drug combination from the network perspective. We also find that drug combinations are more likely to modulate functionally related pathways. CONCLUSIONS: This study confirms that the molecular networks where drug combinations exert their functions can indeed provide important insights into the underlying rules of effective drug combinations. We hope that our findings can help shortcut the expedition of the future discovery of novel drug combinations. BioMed Central 2012-05-08 /pmc/articles/PMC3348050/ /pubmed/22595004 http://dx.doi.org/10.1186/1471-2105-13-S7-S7 Text en Copyright ©2012 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Proceedings
Wang, Yin-Ying
Xu, Ke-Jia
Song, Jiangning
Zhao, Xing-Ming
Exploring drug combinations in genetic interaction network
title Exploring drug combinations in genetic interaction network
title_full Exploring drug combinations in genetic interaction network
title_fullStr Exploring drug combinations in genetic interaction network
title_full_unstemmed Exploring drug combinations in genetic interaction network
title_short Exploring drug combinations in genetic interaction network
title_sort exploring drug combinations in genetic interaction network
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348050/
https://www.ncbi.nlm.nih.gov/pubmed/22595004
http://dx.doi.org/10.1186/1471-2105-13-S7-S7
work_keys_str_mv AT wangyinying exploringdrugcombinationsingeneticinteractionnetwork
AT xukejia exploringdrugcombinationsingeneticinteractionnetwork
AT songjiangning exploringdrugcombinationsingeneticinteractionnetwork
AT zhaoxingming exploringdrugcombinationsingeneticinteractionnetwork